VANESSA SLUDER: Open Payments
NPI 1629301106 · SENATOBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 22 payments from 6 companies in 2025. Trend: 2023 $118 · 2024 $405 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| Novo Nordisk Inc | 7 | $134 |
| Lilly USA, LLC | 5 | $82 |
| ABBVIE INC. | 2 | $47 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Ozempic, AIRSUPRA, MOUNJARO, Auvelity, CREON, FARXIGA, UBRELVY, Rybelsus.
Industry payments across MS — which companies pay providers there.
